Pallavi Lagisetty et al.
FULL PAPERS
centrated. The crude reaction products were purified by
column chromatography using appropriate solvents (listed
under the individual compound headings in the Supporting
Information). Fractions containing pure product were com-
bined, evaporated and dried under vacuum.
Med. Chem. 2001, 8, 385–423; c) J. Zemlicka, Pharma-
col. Ther. 2000, 85, 251–266; d) D. M. Huryn, M.
Okabe, Chem. Rev. 1992, 92, 1745–1768.
[3] For reviews, see: a) M. K. Lakshman, Curr. Org. Synth.
2005, 2, 83–112; b) L. A. Agrofoglio, I. Gillaizeau, Y.
Saito, Chem. Rev. 2003, 103, 1875–1916; c) M. K.
Lakshman, J. Organomet. Chem. 2002, 653, 234–251.
[4] a) V. Aucagne, S. Berteina-Raboin, P. Guenot, L. A.
Agrofoglio, J. Comb. Chem. 2004, 6, 717–723; b) D. E.
Bergstrom, M. K. Ogawa, J. Am. Chem. Soc. 1978, 100,
8106–8112.
Typical Procedure for the Arylation of 8-Ethenyl-
3’,5’-bis-O-(tert-butyldimethylsilyl)-2’-deoxyadenosine
(5)
With aryl iodides and bromides (Conditions A): A mixture
of Pd
N
N
[5] A. Bråthe, L.-L. Gundersen, F. Rise, A. B. Eriksen,
A. V. Vollsnes, L. Wang, Tetrahedron 1999, 55, 211–
228.
mmol), Et3N(68 mL, 0.49 mmol), 8-vinylnucleoside 5 (50 mg,
0.10 mmol) and aryl iodide or aryl bromide (2 mol equivs.)
in DMF (1.0 mL) was prepared in an oven-dried vial,
equipped with a stirring bar. The reaction mixture was flush-
ed with N2 gas, sealed with a Teflon lined cap, and placed in
a sand bath that was maintained at 100–1058C. Reactions
were monitored by TLC and upon consumption of the start-
ing material, the reaction mixtures were diluted with EtOAc
(10 mL) and washed with brine (5 mL) and then twice with
water. The organic layer was separated, dried (Na2SO4) and
concentrated. The crude reaction products were purified by
column chromatography using appropriate solvents (listed
under the individual compound headings in the Supporting
Information). Fractions containing pure product were com-
bined, evaporated and dried under vacuum.
ˇ
[6] T. Tobrman, D. Dvorµk, Tetrahedron Lett. 2004, 45,
273–276.
[7] J. B. Shaab, B. D. Buzzeo, L. Ng, J. D. Corbin, J. Biol.
Chem. 1991, 266, 24320–24326.
[8] R. A. Anderson, D. J. Graves, Biochemistry 1973, 12,
1895–1900.
[9] R. M. Moriarty, W. R. Epa, A. K. Awasthi, Tetrahedron
Lett. 1990, 31, 5877–5880.
[10] a) S. Manfredini, P. G. Baraldi, R. Bazzanini, M. Mar-
angoni, D. Simoni, J. Balzarini, E. De Clercq, J. Med.
Chem. 1995, 38, 199–203; b) G. Sµgi, L. Ötvçs, S.
Ikeda, G. Andrei, R Snoeck, E. De Clercq, J. Med.
Chem. 1994, 37, 1307–1311; c) A. A. Van Aerschot, P.
Mamos, N. J. Weyns, S. Ikeda, E. De Clercq, P. A. Her-
dewijn, J. Med. Chem. 1993, 36, 2938–2942; d) P.
Mamos, A. A. Van Aerschot, N. J. Weyns, P. A. Herde-
wijn, Tetrahedron Lett. 1992, 33, 2413–2416.
[11] C. B. Ziegler, Jr., R. F. Heck, J. Org. Chem. 1978, 43,
2941–2946.
Supporting Information
Analysis of methods for the synthesis of 4 and 5, details of
their synthesis and characterization, complete characteriza-
tion data for 6a–n and 7a–n, synthesis and characterization
1
of 8. H N MR of6n showing the trans to cis isomerization.
[12] W. A. Herrmann, C. Brossmer, K. Öfele, C.-P. Reising-
er, T. Priermeier, M. Beller, H. Fischer, Angew. Chem.
1995, 107, 1989–1992; Angew. Chem. Int. Ed. Engl.
1995, 34, 1844–1848.
Acknowledgements
[13] M. R. Netherton, G. C. Fu, Org. Lett. 2001, 3, 4295–
4298.
[14] C. Yi, R. Hua, Tetrahedron Lett. 2006, 47, 2573–2576.
[15] Y. Ben-David, M. Portnoy, M. Gozin, D. Milstein, Or-
ganometallics 1992, 11, 1995–1996.
This work was supported by NSF Grant CHE-0640417, a
PSC-CUNY 38 award and partially by NIH Grant S06
GM008168–24S1. Acquisition of a mass spectrometer was
funded by NSF Grant CHE-0520963 (M.K.L). Dr. Chris
Woltermann (FMC Corporation) is thanked for a generous
gift of several of the alkyl phosphine tetrafluoroborate salts.
[16] K. Selvakumar, A. Zapf, M. Beller, Org. Lett. 2002, 4,
3031–3033.
[17] The predominant trans-olefin isomers had a Jtrans
=
15.3–16.6 Hz whereas in those cases where a cis-isomer
was observed the Jcis =12.2–12.8 Hz. The vinyl protons
of the trans-isomers were more downfield shifted than
those of the cis.
References
[1] a) Nucleic Acids in Chemistry and Biology, 3rd edn.,
(Eds.: G. M. Blackburn, M. J. Gait, D. Loakes, D. M.
Williams), RSC Publishing, Cambridge, UK, 2006;
b) C. Simons, Nucleoside Mimetics: Their Chemistry
and Biological Properties, Gordon and Breach, Amster-
dam, 2001; c) Perspectives in Nucleoside and Nucleic
Acid Chemistry, (Eds.: M. V. Kisakürek, H. Rosemey-
er), Verlag Helvetica Chimica Acta, Zurich and Wiley-
VCH, Weinheim, 2000; d) R. J. Suhadolnik, Nucleo-
sides and Nucleic Acids as Biological Probes, Wiley,
New York, 1979.
[18] For reviews, see: a) A. R. Muci, S. L. Buchwald, Top.
Curr. Chem. 2002, 219, 131–209; b) B. H. Yang, S. L.
Buchwald, J. Organomet. Chem. 1999, 576, 125–146;
c) J. F. Hartwig, Acc. Chem. Res. 1998, 31, 852–860;
d) J. F. Hartwig, Angew. Chem. 1998, 110, 2154–2177;
Angew. Chem. Int. Ed. 1998, 37, 2046–2067.
[19] F. N. Ngassa, K. A. DeKorver, T. S. Melistas, E. A.-H.
Yeh, M. K. Lakshman, Org. Lett. 2006, 8, 4613–4616.
[20] N. Kohyama, T. Katashima, Y. Yamamoto, Synthesis
2004, 2799–2804.
[2] a) L. A. Agrofoglio, S. P. Nolan, Curr. Top. Med. Chem.
2005, 5, 1541–1558; b) E. Ichikawa, K. Kato, Curr.
608
ꢀ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2008, 350, 602 – 608